AC
BSX icon

AlphaCore Capital’s Boston Scientific BSX Stock Holding History

AlphaCore Capital’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$410K Buy
6,534
+439
+7% +$35.1K 0.01% 603
2025
Q4 		$581K Buy
6,095
+1,145
+23% +$112K 0.01% 569
2025
Q3 		$483K Buy
4,950
+2,518
+104% +$261K 0.02% 463
2025
Q2 		$261K Buy
+2,432
New +$246K 0.01% 514

Other funds holding BSX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

AlphaCore Capital's BSX Position: Q1 2026 in Review

AlphaCore Capital increased its Boston Scientific (BSX) stake by 7.2% in Q1 2026, buying an estimated $35.1K and bringing the position to 6,534 shares worth $410K. The position accounts for 0.01% of the portfolio, ranked #603.

AlphaCore Capital first reported a position in BSX in Q2 2025 and has held it in 4 quarters since. The position peaked at $581K in Q4 2025. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • AlphaCore Capital held 6,534 shares of Boston Scientific worth $410K as of Q1 2026.
  • AlphaCore Capital bought 439 Boston Scientific shares in Q1 2026, an estimated $35.1K.
  • Boston Scientific made up 0.01% of AlphaCore Capital's portfolio in Q1 2026, its #603 holding.
  • AlphaCore Capital first reported a position in Boston Scientific in Q2 2025 and has held it in 4 quarters since.
  • AlphaCore Capital's Boston Scientific position peaked at $581K in Q4 2025.
  • 1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on AlphaCore Capital's 13F filing for Q1 2026, filed 15 May 2026.